Advanced Search
Users Online: 414
About
About Journal
Editorial Board
Acknowledgments
Articles
Ahead of Print
Current Issue
Archives
Authors
Submit Article
Instructions
Search
Simple Search
Advanced Search
Image Search
Medline Search
Contact Us
Login
Sign Up
Subscriber Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Table of Contents
November 2021
Volume 10 | Issue 6
Page Nos. 241-290
Online since Tuesday, November 30, 2021
Accessed 15,380 times.
PDF access policy
Journal allows immediate open access to content in HTML + PDF
View issue as eBook
Issue statistics
RSS
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
META-ANALYSIS
Effects of
L
-arginine on preeclampsia risks and maternal and neonatal outcomes: A systematic review and meta-analysis
p. 241
Shonitha Sagadevan, Oorvashree Sri Hari, Mohamed Jahangir Sirajudeen, Gopi Ramalingam, Roopa Satyanarayan Basutkar
DOI
:10.4103/2305-0500.331261
Objective:
To summarize whether the supplementation of
L
-arginine in pregnant women helps in management of preeclampsia and its impact on maternal and neonatal outcomes.
Methods:
Studies conducted from the past 17 years (1999 to 2016). were referred from database like Cochrane Central Registry of Controlled Trials (CENTRAL), Scopus, Google Scholar and PubMed. Out of 134 studies, 7 studies were included.
L
-arginine
versus
placebo was considered for quantitative analysis. Modified Cochrane data extraction form was used to collect the data. The risk of bias was assessed using Cochrane’s risk of bias assessment tool in RevMan 5.4 and the summary of findings was determined using GradePro software.
Results:
L
-arginine showed a significant reduction of preeclampsia [odds ratio (OR) 0.38; 95% confidence interval
(CI)
0.25, 0.58)]. There was a significant reduction in systolic blood pressure [mean difference (MD) -2.47; 95%
CI
-4.53, -0.42] and diastolic blood pressure (MD -0.97; 95%
CI
-3.83, 1.89). The effects of
L
-arginine on secondary outcomes like maternal gestational age, latency, neonatal weight, and appearance, pulse, grimace, activity, respiration (APGAR) score at 1st and 5th minute were not statistically significant.
Conclusions:
L
-arginine supplementation is effective in lowering systolic and diastolic blood pressure of preeclamptic patients. However, it has no noticeable effects on maternal and neonatal outcomes.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
REVIEW ARTICLE
Neutrophil-lymphocyte ratio in pregnancy-associated maternal complications: A review
p. 252
Monalisa Biswas, Vijetha Shenoy Belle, Nihaal Maripini, Krishnananda Prabhu
DOI
:10.4103/2305-0500.331262
Pregnancy associated diseases/disorders are associated with significant maternal and neonatal morbidities and mortalities. Devising/validating cost effective and easily accessible predictive, diagnostic and risk stratification markers are critical to the management and improved outcome in these diseases. Inflammation forms the backbone of most of the routinely encountered maternal complications of pregnancy. Hematological markers can be considered as a direct reflection of the systemic inflammatory milieu. Recently, the neutrophil lymphocyte ratio has been explored for its potential to assess the severity of inflammation and thus the severity of the underlying disorder. The neutrophil-lymphocyte ratio has gained scientific attention as a potential prognostic/predictive marker of acute as well as chronic inflammatory diseases including gynecological and reproductive disorders. This present study reviews the mechanistic role of neutrophils and lymphocytes in fueling or propagating the inflammatory cascades in the three most common maternal complications of pregnancy and the evidence of clinical importance of the neutrophil to lymphocyte ratio in predicting, diagnosing, and prognosticating pregnancy-associated complications.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
ORIGINAL ARTICLES
Quality of life of infertile couples in the Gaza Strip, Palestine
p. 262
Suha Baloushah, Samira Barjasteh, Aymen Elsous, Ali Aldirawi, Soha Abu Eid, Atef Masad
DOI
:10.4103/2305-0500.331263
Objective:
To investigate the quality of life of infertile couples who seek
in vitro
fertilizations (IVFs) by gender in the Gaza Strip, Palestine.
Methods:
A cross-sectional study was conducted, from February 2019 to November 2019, among 383 infertile couples selected through convenient sampling. A valid and reliable Arabic version of the fertility quality of life questionnaire (FertiQoL) was used in data collection. One way analysis of variance and independent
t
-test were applied to compare between males and females.
Results:
The mean age of males and females was (34.54±8.54) years and (29.28±6.71) years, respectively. More than half of them had university degree (64% and 60%, respectively). The mean duration of infertility was (5.66±3.54) years. The mean males’ scores of FertiQoL and its subscales (emotion, mind/body, social, core, tolerability, and treatment) were significantly higher than females’ scores (
P
<0.05).
Conclusions:
Males have higher scores of FertiQoL and its subscales than females. The mean score of FertiQoL increases with better education, but decreases with increase of age, duration of marriage, duration of infertility and number of IVF attempts. Routine psychological assessment and counseling are necessary for infertile women taking into considerations factors affecting their quality of life.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Association between
eNOS
gene promoter polymorphism (-786T>C) and idiopathic recurrent pregnancy loss in Iranian women
p. 269
Maryam Sadat Jalili, Samira Asadollahi, Seyed Morteza Seifati, Hamid Reza Ashrafzadeh, Nasrin Ghasemi
DOI
:10.4103/2305-0500.331264
Objective:
To investigate the frequency of -786T>C variant in endothelial nitric oxide synthase
(eNOS)
gene promoter in Iranian women with recurrent pregnancy loss.
Methods:
Blood samples were obtained from 100 unrelated women affected by recurrent pregnancy loss and 100 unaffected women as the controls. Genomic DNA was extracted and -786T>C polymorphism in
eNOS
gene promoter was investigated by PCR-RFLP method. Statistical analyses and Hardy-Weinberg equilibrium in the groups of patients and controls were performed by Chi-square test and SPSS standard software (Version 21).
Results:
The frequency of homozygous TT was 40% in cases and 46% in the control group; the frequency of CC was 7% in cases and 5% in the control group; frequency heterozygote TC was 53% in cases and 49% in the control group. Genotype frequencies between the two groups showed no significant differences (
P
>0.05).
Conclusions:
The -786T>C polymorphism is not more frequent in recurrent pregnancy loss in this population.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Folic acid protects against fluoride-induced oxidative stress and testicular damage in rats
p. 274
Ray Dibyendu, Chatterjee Tiasa, Monalisha Das, Panda Pradip, Mukherjee Sandip
DOI
:10.4103/2305-0500.331265
Objective:
To investigate the effects of folic acid on testicular oxidative damage in sodium fluoride-induced male Wistar rats.
Methods:
A total of 24 male Wistar rats were divided into 4 groups: the control, sodium fluoride (fed with 100 mg/L sodium fluoride through drinking water orally for 21 days), folic acid (36 μg/kg body weight/day, orally), and sodium fluoride plus folic acid (received similar dose orally) groups. At the end of 21 days, epididymal sperm parameters, biochemical analysis of testicular tissue, and serum hormonal levels were performed along with histopathological studies.
Results:
Sodium fluoride intoxication resulted in marked reduction in gonado somatic index, serum luteinizing hormone, and testosterone level along with 3 β -hydroxysteroid dehydrogenase and 17 β -hydroxysteroid dehydrogenase activities. In addition, reduction in sperm density, as well as loss of sperm motility and sperm viability, were also observed. Besides, increased levels of testicular malondialdehyde, nitrite, interleukin-6 and tumor necrosis factor- α as well as decreased levels of superoxide dismutase and catalase activities and reduced glutathione content were found to be associated with this toxicity. Folic acid co-treatment, on the other hand, could prevent all the sodium fluoride-induced testicular pathophysiology and oxidative stress related parameters. Histological examinations of testicular sections from the experimental rats supported these results.
Conclusions:
Combining all, this study suggests that being an antioxidant, folic acid plays a beneficial role against fluoride-induced adverse effects on the male reproductive system.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Protective effects of honey compound syrup on busulfan-induced azoospermia in male rats
p. 284
Seyyed Shamsadin Athari, Keivan Lorian, Haniye Kashafroodi, Saadat Ghafarzadeh, Rasool Choopani
DOI
:10.4103/2305-0500.331266
Objective:
To evaluate the protective effects of honey compound syrup on sperm count and testis tissue in rats.
Methods:
Thirty rats were randomly assigned to five groups. The control group received 1 mL normal saline with dimethyl sulfoxide intraperitoneally; the busulfan group received busulfan 10 mg/kg body weight at the first and twenty-first days of the experiment
via
intraperitoneal injection; the last three groups received busulfan 10 mg/kg body weight to induce azoospermia, and then received 1.0, 1.5, or 2.0 mg/kg honey compound syrup, respectively, after induction of azoospermia. After administration, the testis and epididymis of all rats were removed. Then, reproductive organ weight and sperm parameters (sperm concentration, epididymal sperm reserve and daily sperm production) were measured. After hematoxylin-eosin staining, seminiferous tubule cells and diameters were assessed.
Results:
Busulfan damaged the testis tissue and impaired spermatogenesis. Administration of honey compound syrup in three doses improved testis tissue and spermatogenesis. The protective effects of honey compound syrup may relate to the antioxidant properties of honey and other compounds in this syrup.
Conclusions:
Administration of honey compound syrup could be an ameliorative agent for the side effects of chemotherapy drugs such as busulfan on the male reproductive system.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Next Issue
Previous Issue
SUBMIT ARTICLE
POPULAR ARTICLES
JOIN AS REVIEWER
GET EMAIL ALERTS
RECOMMEND
© Asian Pacific Journal of Reproduction | Published by Wolters Kluwer -
Medknow
Sitemap
|
What's New
|
Feedback
|
Disclaimer
|
Privacy Notice
|
FAQ
Online since 14
th
Aug 2017.